Gene: BSDC1
Official Full Name: BSD domain containing 1provided by HGNC
Gene Summary: Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19367 | BSDC1 Knockout cell line (HeLa) | Human | BSDC1 | 1:3~1:6 | Negative | Online Inquiry |
KO19368 | BSDC1 Knockout cell line (HCT 116) | Human | BSDC1 | 1:2~1:4 | Negative | Online Inquiry |
KO19369 | BSDC1 Knockout cell line (HEK293) | Human | BSDC1 | 1:3~1:6 | Negative | Online Inquiry |
KO19370 | BSDC1 Knockout cell line (A549) | Human | BSDC1 | 1:3~1:4 | Negative | Online Inquiry |
BSDC1 Gene Knockout Cell Lines are genetically engineered cell models designed to provide researchers with an innovative tool for studying the functions of the BSDC1 gene. Through targeted gene editing techniques, these cell lines exhibit a complete disruption of BSDC1 gene expression, resulting in the loss of its encoded protein functions. This unique attribute allows for the observation of phenotypic changes and the subsequent elucidation of the gene’s role in various biological processes, including cell differentiation, signaling pathways, and disease mechanisms.
The key function of the BSDC1 gene knockout is its ability to provide a controlled environment to examine the consequences of gene loss. By utilizing CRISPR-Cas9 technology, the knockout cell lines maintain a stable deletion of the target gene, which can significantly expedite the research process. Researchers can utilize these cell lines in functional assays, drug screening, and molecular interaction studies, thereby enhancing the understanding of BSDC1's involvement in pathological contexts such as cancer, neurological disorders, and metabolic syndromes.
In comparison to alternative models, such as traditional knockdown approaches that often yield transient effects, the BSDC1 Gene Knockout Cell Lines offer a permanent alteration, affording researchers a more reliable platform for longitudinal studies. Moreover, the development of these cell lines is rooted in rigorous scientific validation, ensuring reproducibility and consistency in experimental setups, which are paramount in both academic research and clinical investigations.
The value of BSDC1 Gene Knockout Cell Lines extends beyond basic research; they can also serve as a crucial tool in the development of therapeutic interventions targeting disorders linked with BSDC1 dysfunction. The capability to perform high-throughput screening in these specific models could lead to significant advancements in drug discovery and personalized medicine.
Our company specializes in creating cutting-edge genetic tools and cellular models, driven by a commitment to advancing scientific knowledge and clinical applications. With a focus on precision and quality, we provide researchers and clinicians with the necessary resources to explore complex biological phenomena comprehensively.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.